| Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease D Nyholm, AIM Nilsson Remahl, N Dizdar, R Constantinescu, B Holmberg, ... Neurology 64 (2), 216-223, 2005 | 541 | 2005 |
| Optimizing levodopa pharmacokinetics: intestinal infusion versus oral sustained-release tablets D Nyholm, H Askmark, C Gomes–Trolin, T Knutson, H Lennernäs, ... Clinical neuropharmacology 26 (3), 156-163, 2003 | 300 | 2003 |
| Duodenal levodopa infusion in Parkinson's disease–long‐term experience D Nilsson, D Nyholm, SM Aquilonius Acta Neurologica Scandinavica 104 (6), 343-348, 2001 | 228 | 2001 |
| Pharmacokinetic optimisation in the treatment of Parkinson’s disease: an update D Nyholm Clinical pharmacokinetics 45, 109-136, 2006 | 214 | 2006 |
| Selecting deep brain stimulation or infusion therapies in advanced Parkinson’s disease: an evidence-based review J Volkmann, A Albanese, A Antonini, KR Chaudhuri, CE Clarke, ... Journal of neurology 260, 2701-2714, 2013 | 171 | 2013 |
| Enteral levodopa/carbidopa infusion in advanced Parkinson disease: long-term exposure D Nyholm, T Lewander, A Johansson, PA LeWitt, C Lundqvist, ... Clinical neuropharmacology 31 (2), 63-73, 2008 | 165 | 2008 |
| Duodopa® treatment for advanced Parkinson's disease: a review of efficacy and safety D Nyholm Parkinsonism & related disorders 18 (8), 916-929, 2012 | 132 | 2012 |
| Enteral levodopa/carbidopa gel infusion for the treatment of motor fluctuations and dyskinesias in advanced Parkinson’s disease D Nyholm Expert review of neurotherapeutics 6 (10), 1403-1411, 2006 | 129 | 2006 |
| Pharmacokinetics of Levodopa, Carbidopa, and 3-O-Methyldopa Following 16-hour Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson … D Nyholm, P Odin, A Johansson, K Chatamra, C Locke, S Dutta, ... The AAPS journal 15, 316-323, 2013 | 119 | 2013 |
| Levodopa–carbidopa intestinal gel in patients with Parkinson’s disease: a systematic review K Wirdefeldt, P Odin, D Nyholm CNS drugs 30, 381-404, 2016 | 117 | 2016 |
| Irregular gastrointestinal drug absorption in Parkinson's disease D Nyholm, H Lennernäs Expert opinion on drug metabolism & toxicology 4 (2), 193-203, 2008 | 116 | 2008 |
| Levodopa/carbidopa intestinal gel infusion long‐term therapy in advanced Parkinson’s disease D Nyholm, K Klangemo, A Johansson European Journal of Neurology 19 (8), 1079-1085, 2012 | 115 | 2012 |
| Levodopa pharmacokinetics and motor performance during activities of daily living in patients with Parkinson's disease on individual drug combinations D Nyholm, H Lennernäs, C Gomes–Trolin, SM Aquilonius Clinical neuropharmacology 25 (2), 89-96, 2002 | 105 | 2002 |
| Levodopa‐entacapone‐carbidopa intestinal gel in Parkinson's disease: A randomized crossover study M Senek, EI Nielsen, D Nyholm Movement Disorders 32 (2), 283-286, 2017 | 98 | 2017 |
| Trial of deferiprone in Parkinson’s disease D Devos, J Labreuche, O Rascol, JC Corvol, A Duhamel, ... New England Journal of Medicine 387 (22), 2045-2055, 2022 | 97 | 2022 |
| A new computer method for assessing drawing impairment in Parkinson's disease J Westin, S Ghiamati, M Memedi, D Nyholm, A Johansson, M Dougherty, ... Journal of neuroscience methods 190 (1), 143-148, 2010 | 95 | 2010 |
| Levodopa infusion combined with entacapone or tolcapone in Parkinson disease: a pilot trial D Nyholm, A Johansson, H Lennernäs, H Askmark European Journal of Neurology 19 (6), 820-826, 2012 | 92 | 2012 |
| Irreversible motor impairment in young addicts–ephedrone, manganism or both? K Sikk, P Taba, S Haldre, J Bergquist, D Nyholm, G Zjablov, T Asser, ... Acta Neurologica Scandinavica 115 (6), 385-389, 2007 | 88 | 2007 |
| Levodopa infusion therapy in Parkinson disease: state of the art in 2004 D Nyholm, SM Aquilonius Clinical neuropharmacology 27 (5), 245-256, 2004 | 87 | 2004 |
| A computer vision framework for finger-tapping evaluation in Parkinson's disease T Khan, D Nyholm, J Westin, M Dougherty Artificial intelligence in medicine 60 (1), 27-40, 2014 | 86 | 2014 |
